Engineered Plasmonic and Fluorescent Nanomaterials for Biosensing, Motion, Imaging, and Therapeutic Applications

Abstract The field of nanophotonics has seen remarkable advances, with gold‐based materials standing out. By precisely fine‐tuning the size and shape of metal nanoparticles (NPs), such as gold nanoparticles (AuNPs), it has been possible to gain control over light interaction, modulating localized surface plasmon resonance (LSPR), a phenomenon that involves the collective oscillation of free conduction electrons. This has opened the path toward more powerful biomedical applications, including surface‐enhanced Raman spectroscopy (SERS) and photothermal therapy (PTT). When AuNPs dimensions fall below 2 nm, they become gold nanoclusters (AuNCs), losing the LSPR but acquitting fluorescence due to their molecule‐like behavior. This unique feature makes them ideal for high‐resolution imaging, biomarker detection, and advanced therapies. Beyond traditional uses, the recent inclusion of AuNPs into nanomotors (NMs) enhances precise in vivo tracking and targeted drug delivery. This review highlights the different applications of plasmonic nanomaterials with particular emphasis on AuNPs and AuNCs as a function of their shapes, sizes, and stabilization ligands. Moreover, it dives into the biosensing applications of plasmonic materials by addressing their so‐called far‐field and near‐field optical properties, giving a detailed overview of different high‐sensitivity immunoassays and biosensing. A comprehensive outlook on the evolution of plasmonic‐based materials for the next therapies is provided.